Cargando…
Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
Transfusion‐dependent thalassaemia (TDT) requires red blood cell concentrates (RBCC) to prevent complications of anaemia, but carries risk of infection. Pathogen reduction of RBCC offers potential to reduce infectious risk. We evaluated the efficacy and safety of pathogen‐reduced (PR) Amustaline‐Glu...
Autores principales: | Aydinok, Yesim, Piga, Antonio, Origa, Raffaella, Mufti, Nina, Erickson, Anna, North, Anne, Waldhaus, Katie, Ernst, Christine, Lin, Jin‐Sying, Huang, Norman, Benjamin, Richard J., Corash, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771954/ https://www.ncbi.nlm.nih.gov/pubmed/31148155 http://dx.doi.org/10.1111/bjh.15963 |
Ejemplares similares
-
Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione
por: North, Anne K., et al.
Publicado: (2020) -
Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019) -
Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
por: Infanti, Laura, et al.
Publicado: (2019) -
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
por: Snyder, Edward L., et al.
Publicado: (2022) -
Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019)